MedTrace Logo

The Role of Expectancy for Cognitive Enhancement in College Students Using Prescription Stimulants Nonmedically

NCT04635826 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2025-04-07

No results posted yet for this study

Summary

We propose to evaluate the interaction between expectations of receiving stimulants, neurophysiological activity and enhancement of cognitive performance using fMRI.

Conditions

  • Prescription Stimulants
  • Expectations
  • Deception

Interventions

DRUG

Adderall 10Mg Tablet

Participants will be administered Adderall

DRUG

Placebo

Participants will be administered placebo

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Karen Cropsey, PsyD · University of Alabama at Birmingham

  • David Knight, PhD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2029-07-31
Completion
2030-07-31
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04635826 on ClinicalTrials.gov